NEW YORK (GenomeWeb News) – Luminex said this week that it has launched its xTAG cystic fibrosis 39 Kit v2 and xTAG Cystic Fibrosis 71 Kit v2 as CE IVD Marked products in Europe. The multiplex tests screen for common CFTR gene mutations and for additional mutations that are typically found in specific ethnic populations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.